Adam R Craig insider trades
Open-market stock purchases and sales by Adam R Craig, Executive Chairman at X4 Pharmaceuticals, Inc, from SEC Form 4 filings since Feb 29, 2012.
Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +17%.